Leading experts in immunology, immuno-oncology and cancer cell therapies bring their expertise to advance development and clinical goals of companyDublin, Ireland, May 25, 2022 – RemedyBio, a biotech company pioneering its proprietary ultra-high throughput single cell Nanoreactor™ platform for discovery and developm.
Pfizer picks from Roche's executive team, snagging pharma early R&D leader William Pao as the Big Pharma's next chief development officer. Leo Pharma poaches from . a Danish meme stock for its new CEO, who will lead a reorganization of the dermatology biopharma. And Sio Gene Therapies CEO Cheruvu is out the door as Parkinson's program also hits the exit.